AMÉRICO GARCÍA Director General of Mexico and Latin America at Apotex
View from the Top
Américo García
Director General of Mexico and Latin America
Apotex
A quick response and high adaptability are vital during the pandemic. How has Apotex reacted to the crisis?
Generics
Roundtable
Gurulinga Konanur
Gurulinga Konanur
Director General of Hetero Mexico

There are few API manufacturers in Mexico. As a result, we hold strong ground in Mexico. The quality of a medication relies entirely on the quality of the API. Developing an API requires significantly more investment in R&D than in manufacturing of the finished product. We invest heavily in R&D and we often begin planning them over 10 years before they go off patent. This helps us to offer products to clients at a much more advanced or early stage of product development. We see the biggest competition coming from Asian companies that offer their products at a low price, but they lack great services and speed to reach the market. Hetero has a 500ha chemical complex in Vizag, India that manufactures 24/7, which allows us to offer a high volume of high-quality products at affordable costs.

Stronger regulations on generics production, along with high costs of patent medications, have led to a boom in the Mexican generics market
Analysis chart Generics
Analysis
Generics are always an attractive alternative for those who need medication at accessible prices, be they individuals or healthcare systems.
Americo Garcia
View from the Top
Américo García
Director General
Mexico and Latin America at Apotex
Apotex manufactures and commercializes generic and innovative drugs in more than 115 countries.
Américo García
View from the Top
Américo García
Director General of Mexico and Latin America
Apotex
Apotex is a pharmaceutical company, with over 10,000 people employed worldwide in its research, development, manufacturing and distribution facilities
Américo García
View from the Top
Américo García
Director General Latin America
Apotex
Apotex is a pharmaceutical company, with over 10000 people employed worldwide in its research, development, manufacturing and distribution facilities.
Américo García
View from the Top
Américo García
Director General
Apotex Latin America
The Mexican pharmaceutical industry has interesting retail and public growth opportunities.
Américo García
View from the Top
Américo García
Director General
Apotex Latin America
We are now reaping the rewards of the transformation, including obtaining the Good Manufacturing Practices (GMP) certification by COFEPRIS
MHS 2015
News Article
Mexico Health Summit 2015: Innovations in Supply Chain, in Manufacturing and Distribution panel highlights
Subscribe to Apotex